Can mirtazapine cause urinary problems such as difficulty initiating urination, reduced urine flow, or urinary retention?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Mirtazapine and Urinary Problems

Mirtazapine can cause urinary problems, particularly urinary retention and urinary incontinence, especially in older males with benign prostatic hyperplasia (BPH), though the overall incidence appears relatively low at approximately 2% for urinary frequency in clinical trials.

Evidence from FDA Drug Label

The FDA label for mirtazapine 1 documents urinary frequency occurring in 2% of patients versus 1% with placebo in 6-week controlled trials. While the label does not explicitly list urinary retention as a common adverse effect, it is known to be substantially excreted by the kidney (75%), which has implications for patients with renal impairment.

Clinical Evidence and Risk Factors

High-Risk Populations

Older males with BPH are at particularly elevated risk for mirtazapine-induced urinary retention. A case report 2 documented acute urinary retention occurring within 24 hours of mirtazapine initiation in a 70-year-old man with underlying BPH. The case emphasizes that mirtazapine inevitably induces acute urinary retention in older males with BPH, despite being considered to have lower anticholinergic activity than tricyclic antidepressants.

Types of Urinary Problems

Mirtazapine can cause both:

  • Urinary retention/voiding difficulties: More common in males with BPH 2
  • Urinary incontinence: A case report 3 documented complete urinary incontinence in a 55-year-old patient that fully resolved after discontinuing mirtazapine

Mechanism and Comparative Risk

A systematic review 4 found that antidepressants generally cause more voiding symptoms than storage symptoms. While tricyclic antidepressants and SNRIs showed higher odds ratios for voiding dysfunction compared to SSRIs (OR: 3.30; CI: 1.90-5.72), mirtazapine's mechanism differs. Despite having lower anticholinergic activity than tricyclics, mirtazapine affects adrenergic and dopaminergic regulatory mechanisms in the central nervous system that can impair lower urinary tract function 3.

Clinical Management Algorithm

Pre-Treatment Assessment

  • Screen all patients for:
    • History of BPH or lower urinary tract symptoms
    • Baseline voiding patterns
    • Current urinary medications (alpha-blockers, anticholinergics)
    • Age >65 years (higher risk)

Monitoring During Treatment

  • Ask specifically about difficulty initiating urination, reduced urine flow, or new incontinence at each follow-up
  • Be particularly vigilant in the first 24-48 hours after initiation 2
  • Consider post-void residual measurement in high-risk patients

If Urinary Problems Develop

  1. Immediate action: Discontinue or reduce mirtazapine dose
  2. Acute retention: Requires urinary catheterization 2
  3. Expected timeline: Full continence restoration typically occurs within days of discontinuation 3
  4. Alternative antidepressants: Consider SSRIs, which have lower odds of voiding dysfunction than mirtazapine 4

Special Populations

Elderly Patients

The FDA label 1 specifically warns that sedating drugs like mirtazapine may cause confusion and over-sedation in the elderly, and elderly patients may be at greater risk of developing hyponatremia. Pharmacokinetic studies show decreased clearance in elderly patients, necessitating conservative dosing starting at the low end of the range.

Patients with Renal Impairment

Since mirtazapine is 75% renally excreted 1, patients with moderate to severe renal impairment require dose reduction and more frequent monitoring, as plasma levels may be increased.

Critical Pitfalls to Avoid

  • Do not assume mirtazapine is "safe" for urinary function simply because it has lower anticholinergic activity than tricyclics—case reports demonstrate it can still cause significant urinary problems 2, 3
  • Do not overlook BPH history during pre-treatment assessment, as this is the single most important risk factor
  • Do not attribute new urinary symptoms to aging or BPH progression without considering mirtazapine as the cause
  • Do not continue mirtazapine if acute urinary retention develops—discontinuation is necessary 2

The evidence from opioid guidelines 5 notes that urinary retention occurs in 25% of postoperative patients on opioids and is more frequent in elderly males with BPH, reinforcing that any medication with potential effects on the micturition pathway requires heightened vigilance in this population.

References

Related Questions

I am experiencing urinary retention that began before I started glycopyrrolate for hyperhidrosis (while also taking quetiapine); how should I evaluate and manage this condition?
Can a 62-year-old woman develop urinary retention from clonazepam?
Is clonazepam causing my urinary retention?
Can lorazepam (Ativan) cause urinary retention?
Which non‑tricyclic, non‑SSRI antidepressants are appropriate for a patient at risk of urinary retention?
What is the false‑positive rate of the 4Kscore test for detecting clinically significant prostate cancer in men aged 45 years and older with elevated PSA and no prior prostate cancer diagnosis?
What does a grey tympanic membrane with normal appearance indicate and what management, if any, is required?
When should lamotrigine be discontinued?
In an elderly patient with isolated lower‑lip swelling who is taking aspirin, diclofenac (Voltaren), a statin, lisinopril, vancomycin, albuterol, furosemide (Lasix), and a sulfate‑containing medication, which drug is most likely responsible?
Does ciprofloxacin (Cipro) cause pedal edema?
What is nifedipine‑lidocaine rectal ointment used for?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.